NorthX has been manufacturing biologics to GMP standards since 1992.
In 2021 NorthX was designated a national innovation hub for advanced therapies and vaccines and has the ambition to become a leading cell and gene therapy manufacturer and partner for innovative drug development companies.
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze